4D MRI parameters linked to cardiovascular and cancer disease outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective registry at Ulsan University Hospital enrolling 1,000 adults undergoing cardiac MRI. Participants receive an additional 4D MRI sequence during the same imaging session, which does not affect clinical care. The study analyzes quantitative 4D MRI parameters to see if they relate to the occurrence, severity, and prognosis of major chronic diseases, aiming to identify potential imaging biomarkers. It does not involve changes to treatment plans and relies on observational data collected during standard care. Eligibility includes adults 19 and older who can consent and for whom an extra 4D sequence is performed.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 19 years and older undergoing clinically indicated Cardiac MRI at Ulsan University Hospital
* Participants who undergo an additional 4D MRI sequence during the same imaging session
* Participants who are able to understand the study and provide written informed consent

Exclusion Criteria:

* Individuals aged \< 19 years
* Individuals with cognitive impairment or communication difficulties unable to provide informed consent
* Poor-quality MRI images that are not suitable for analysis
* Individuals deemed inappropriate for study participation by the investigator

Where it's running

• Ulsan University Hospital
  Ulsan, Ulsan, South Korea Recruiting

Study contacts

• Study coordinator: Gyung-Min Park MD, PhD
• Email: gmpark@uuh.ulsan.kr
• Phone: 82-52-250-8993

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease

  This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.

  Recruiting Odense University Hospital · Svendborg · NCT07878325

• Petrelintide for weight loss in people with overweight/obesity and heart disease

  This study tests whether petrelintide helps people with overweight or obesity and cardiovascular disease lose weight when added to a reduced-calorie diet and more physical activity, compared with a placebo.

  Recruiting at 3 sites Phase 3 Hoffmann-La Roche · Anniston, Alabama and 2 other locations · NCT07843472

• VERVE-102 for adults with or at high risk for heart disease

  This study tests whether VERVE-102 can lower bad cholesterol (LDL-C) compared with a placebo in adults with plaque buildup or high risk for it.

  Recruiting Phase 2 Verve Therapeutics, Inc. · DeSoto, Texas · NCT07839936

• Clazakizumab for adults with high hsCRP at risk for a heart event

  This study tests whether clazakizumab can lower inflammation and reduce cardiovascular risk in adults with high hsCRP and existing risk factors.

  Recruiting at 32 sites Phase 2 Eli Lilly and Company · Huntsville, Alabama and 45 other locations · NCT07783802

• Improving Care for underserved older Black patients with cardiovascular and other chronic conditions

  This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07748858

• Health program participation in Halsnæs for people with diabetes, COPD, or heart disease

  This project tests whether a municipal health program in Halsnæs helps adults with diabetes, COPD, or cardiovascular disease participate more and stay engaged.

  Recruiting Steno Diabetes Center Copenhagen · Frederiksværk · NCT07641309

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.